YOUR HELP SAVES LIFES
Only through research will we be able to transform cancer into a treatable and controllable disease. Some of the projects we finance are the following.
Programa de Diagnóstico Molecular del Hospital Clínic de Barcelona
El Cancer Center del Hospital Clínic ofrece un enfoque integral del cáncer, aunando una investigación avanzada con un tratamiento multidisciplinar y coordinado. El apoyo de FERO se focaliza en impulsar la investigación que permite un mejor diagnóstico que posibilita un tratamiento más adecuado a los pacientes, ofreciendo además el acceso a nuevas terapias experimentales.
La plataforma investiga nuevos marcadores tumorales y desarrolla tecnologías innovadoras, como la biopsia líquida (detección de cáncer a través de análisis de sangre). También integra los últimos avances en detección del cáncer, utilizando herramientas de bioinformática, Big Data e Inteligencia Artificial. Todo esto proporciona al oncólogo información valiosa para elegir el mejor tratamiento para cada paciente. Además, crea un biobanco de muestras que es muy útil para futuros estudios.
En 2024, 300 pacientes se beneficiaron de un mejor diagnóstico.
ADVANCED MOLECULAR DIAGNOSIS PROGRAM (DIAMAV)
DIAMAV focuses on the molecular characterization of cancer patients' tumors, identifying key molecular alterations in the development of different tumors that may be susceptible to targeted therapies.
With the support of: Mango, AndBank, ISDIN, Agrolimen, Roviralta Foundation, Veritas, and Gandara Foundation
LIQUID BIOPSY IN PEDIATRIC BRAIN CANCER
The project studies circulating DNA in cerebrospinal fluid in pediatric patients with suspected medulloblastoma relapse. This analysis could aid in early detection, differentiate it from false progression, and design more suitable treatments to improve their life expectancy.
With the support of: Joan Ribas Foundation
PRECISION MEDICINE IN ONCOLOGY: DEVELOPMENT OF NEW TECHNOLOGICAL APPROACHES FOR PERSONALIZED TREATMENTS IN IMMUNOTHERAPY
The project focuses on technological innovation for the identification and characterization of new therapeutic targets in cancer patients eligible for experimental immunotherapy in its early stages.
Conducted at INCLIVA (University Clinic Hospital of Valencia) and led by Dr. Mª Desamparados Roda and Dr. Sheila Zúñiga.
With the support of: Foundation for the Promotion of Solidarity Actions.
ADVANCED BREAST CANCER RESEARCH IN MADRID
This project focuses on advanced breast cancer patients and aims to understand which patients respond to certain treatments, why some develop resistance, and predict which other drugs may be more effective. It seeks to improve the quality of life of patients and reduce unnecessary added toxicities.
With the support of: Mary Kay
Programa de Diagnóstico Molecular del Hospital Clínic de Barcelona
El Cancer Center del Hospital Clínic ofrece un enfoque integral del cáncer, aunando una investigación avanzada con un tratamiento multidisciplinar y coordinado. El apoyo de FERO se focaliza en impulsar la investigación que permite un mejor diagnóstico que posibilita un tratamiento más adecuado a los pacientes, ofreciendo además el acceso a nuevas terapias experimentales.
La plataforma investiga nuevos marcadores tumorales y desarrolla tecnologías innovadoras, como la biopsia líquida (detección de cáncer a través de análisis de sangre). También integra los últimos avances en detección del cáncer, utilizando herramientas de bioinformática, Big Data e Inteligencia Artificial. Todo esto proporciona al oncólogo información valiosa para elegir el mejor tratamiento para cada paciente. Además, crea un biobanco de muestras que es muy útil para futuros estudios.
En 2024, 300 pacientes se beneficiaron de un mejor diagnóstico.
ADVANCED MOLECULAR DIAGNOSIS PROGRAM (DIAMAV)
DIAMAV focuses on the molecular characterization of cancer patients' tumors, identifying key molecular alterations in the development of different tumors that may be susceptible to targeted therapies.
With the support of: Mango, AndBank, ISDIN, Agrolimen, Roviralta Foundation, Veritas, and Gandara Foundation
LIQUID BIOPSY IN PEDIATRIC BRAIN CANCER
The project studies circulating DNA in cerebrospinal fluid in pediatric patients with suspected medulloblastoma relapse. This analysis could aid in early detection, differentiate it from false progression, and design more suitable treatments to improve their life expectancy.
With the support of: Joan Ribas Foundation
PRECISION MEDICINE IN ONCOLOGY: DEVELOPMENT OF NEW TECHNOLOGICAL APPROACHES FOR PERSONALIZED TREATMENTS IN IMMUNOTHERAPY
The project focuses on technological innovation for the identification and characterization of new therapeutic targets in cancer patients eligible for experimental immunotherapy in its early stages.
Conducted at INCLIVA (University Clinic Hospital of Valencia) and led by Dr. Mª Desamparados Roda and Dr. Sheila Zúñiga.
With the support of: Foundation for the Promotion of Solidarity Actions.
ADVANCED BREAST CANCER RESEARCH IN MADRID
This project focuses on advanced breast cancer patients and aims to understand which patients respond to certain treatments, why some develop resistance, and predict which other drugs may be more effective. It seeks to improve the quality of life of patients and reduce unnecessary added toxicities.
With the support of: Mary Kay